Bristol Myers Squibb to Take Part in Wolfe Research Virtual Healthcare Conference

NEW YORK--()--Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in a fireside chat at the Wolfe Research Virtual Healthcare Conference, which will be webcast on Wednesday, November 17, 2021. Giovanni Caforio, M.D., Board Chair and Chief Executive Officer, will answer questions about the company at 8:45 a.m. EST.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube, Facebook, and Instagram.

corporatefinancial-news

Contacts

Bristol Myers Squibb

Media:
media@bms.com

Investor Relations:
Nina Goworek
908-673-9711
nina.goworek@bms.com

Release Summary

Bristol Myers Squibb to Take Part in Wolfe Research Virtual Healthcare Conference

$Cashtags

Contacts

Bristol Myers Squibb

Media:
media@bms.com

Investor Relations:
Nina Goworek
908-673-9711
nina.goworek@bms.com